Related Experiment Video

Updated: Sep 20, 2025

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.4K

The progress of peptide vaccine clinical trials in gynecologic oncology

Mi Tang1, Jiang-Hui Cai2, Hao-Yang Diao1

  • 1GCP institution, Chengdu Women's and Children's Center Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, P.R. China.

Human Vaccines & Immunotherapeutics
|June 10, 2022
PubMed

Insights

Peptide vaccines show promise in gynecologic oncology but require further development for licensing. This review analyzes clinical trials and strategies to enhance their immunotherapeutic outcomes.

Area of Science:

  • Gynecologic Oncology
  • Immunotherapy
  • Vaccine Development

Background:

  • Peptide vaccines are synthesized from tumor antigen epitopes and are a type of immunotherapy.
  • They have demonstrated safety and tolerability with promising results in gynecologic oncology.
  • Currently, no peptide vaccine is licensed for use in this field.

Purpose of the Study:

  • To review peptide vaccine clinical trials in gynecology registered by January 1, 2022.
  • To analyze the global progress and achievements of peptide vaccines in gynecologic oncology.
  • To explore novel methods for improving immunotherapeutic outcomes.

Main Methods:

  • Systematic review of clinical trials registered on ClinicalTrials.gov.
  • Analysis of global progress and achievements in peptide vaccine research for gynecologic cancers.
  • Exploration of strategies to enhance vaccine efficacy.

Main Results:

  • Peptide vaccines are well-tolerated and show potential in gynecologic oncology.
  • Despite promising results, no peptide vaccine has been licensed for gynecologic cancers.
  • Various strategies are being investigated to improve treatment efficacy.

Conclusions:

  • Peptide vaccines represent a developing area in gynecologic oncology immunotherapy.
  • Continued research and development are crucial for overcoming current limitations.
  • Novel approaches like adjuvants and combination therapies may enhance outcomes.
Keywords:
Peptideadjuvantcancergynecologymulti-Epitopeneoantigen

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.9K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.4K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.3K